Harvard Bioscience Hires Jeffrey Duchemin As CEO

(RTTNews) - Harvard Bioscience, Inc. (HBIO) said Tuesday that it has hired veteran life science executive Jeffrey Duchemin as its new Chief Executive Officer.

David Green, who has served as Harvard Bioscience's interim Chief Executive Officer since May 15, has resigned from that interim position and will continue in his capacity as the President of Harvard Bioscience until the completion of the company's spin-off of its regenerative medicine subsidiary.

Prior to joining Harvard Bioscience, Duchemin spent 16 years with Becton Dickinson in progressive sales, marketing and executive leadership positions across its three business segments; BD Medical Systems, BD Diagnostic Systems, and BD Biosciences. In October 2012 BD Biosciences, Discovery Labware was acquired by Corning Life Sciences. Duchemin was a Global Business Director for Corning Life Sciences until his recent departure to Harvard Bioscience.